[go: up one dir, main page]

RU93057572A - 6,9-BIS (AMINO-SUBSTITUTED) -BENZO (D) IZOHINOLIN-5,10-DIONA, METHODS OF THEIR RECEIVING, PHARMOCOMPOSITION, METHOD OF TUMOR TREATMENT - Google Patents

6,9-BIS (AMINO-SUBSTITUTED) -BENZO (D) IZOHINOLIN-5,10-DIONA, METHODS OF THEIR RECEIVING, PHARMOCOMPOSITION, METHOD OF TUMOR TREATMENT

Info

Publication number
RU93057572A
RU93057572A RU93057572/04A RU93057572A RU93057572A RU 93057572 A RU93057572 A RU 93057572A RU 93057572/04 A RU93057572/04 A RU 93057572/04A RU 93057572 A RU93057572 A RU 93057572A RU 93057572 A RU93057572 A RU 93057572A
Authority
RU
Russia
Prior art keywords
pharmocomposition
izohinolin
diona
benzo
bis
Prior art date
Application number
RU93057572/04A
Other languages
Russian (ru)
Other versions
RU2129546C1 (en
Inventor
Крэпчо А.Пол
Original Assignee
Дзе Юниверсити оф Вермонт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Юниверсити оф Вермонт filed Critical Дзе Юниверсити оф Вермонт
Priority claimed from PCT/US1992/001606 external-priority patent/WO1992015300A1/en
Publication of RU93057572A publication Critical patent/RU93057572A/en
Application granted granted Critical
Publication of RU2129546C1 publication Critical patent/RU2129546C1/en

Links

Claims (1)

Предлагается соединение формулы в виде свободного основания или его соли с фармацевтически приемлемой кислотой, обладающее цитостатической и противоопухолевой активностью.The proposed compound of the formula in the form of a free base or its salt with a pharmaceutically acceptable acid, which has cytostatic and antitumor activity.
RU93057572A 1991-03-08 1992-03-09 6,9-bis-(aminosubstituted)-benzo[g]isoquinoline-5,10-diones, method of their synthesis, pharmaceutical composition on their basis, a method of tumor suppression in mammals RU2129546C1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US66595491A 1991-03-08 1991-03-08
US665,954 1991-03-08
US82730292A 1992-01-29 1992-01-29
US827,302 1992-01-29
US827.302 1992-01-29
PCT/US1992/001606 WO1992015300A1 (en) 1991-03-08 1992-03-09 6,9 BIS(SUBSTITUTED-AMINO)BENZO[g]ISOQUINOLINE-5,10-DIONES

Publications (2)

Publication Number Publication Date
RU93057572A true RU93057572A (en) 1996-07-20
RU2129546C1 RU2129546C1 (en) 1999-04-27

Family

ID=27099336

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93057572A RU2129546C1 (en) 1991-03-08 1992-03-09 6,9-bis-(aminosubstituted)-benzo[g]isoquinoline-5,10-diones, method of their synthesis, pharmaceutical composition on their basis, a method of tumor suppression in mammals

Country Status (22)

Country Link
EP (2) EP0503537B1 (en)
JP (1) JP3009465B2 (en)
KR (1) KR100193593B1 (en)
AT (1) ATE153018T1 (en)
AU (1) AU663494B2 (en)
BR (1) BR9205740A (en)
CA (1) CA2104582A1 (en)
CZ (1) CZ286180B6 (en)
DE (1) DE69219646T2 (en)
DK (1) DK0503537T3 (en)
ES (1) ES2104753T3 (en)
FI (1) FI103575B (en)
GR (1) GR3024436T3 (en)
HU (1) HU215967B (en)
IE (1) IE920754A1 (en)
IL (1) IL102087A (en)
MX (1) MX9201020A (en)
NZ (1) NZ241868A (en)
RU (1) RU2129546C1 (en)
SG (1) SG66252A1 (en)
TW (1) TW201735B (en)
WO (1) WO1992015300A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA936396B (en) * 1992-09-08 1994-06-13 Univ Vermont 4-Substituted 6,9-bis(substituted-amino)benzo[g] isoquinoline-5,10,diones
US5519029A (en) * 1992-09-08 1996-05-21 Boehringer Mannheim Italia, S.P.A. 2-aminoalkyl-5-aminoalkylamino substituted-isoquinoindazole-6(2H)-ones
US5587382A (en) * 1994-03-28 1996-12-24 Boehringer Mannheim Italia, Spa 6,9-bis[(2-aminoethyl) amino]benzo [g]isoquinoline-5,10- dione dimaleate; an aza-anthracenedione with reduced cardiotoxicity
US5506232A (en) * 1994-03-28 1996-04-09 Boehringer Mannheim Italia S.P.A. 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt
US6747039B2 (en) 2002-03-12 2004-06-08 Albany Molecular Research, Inc. Aza-benzothiopyranoindazoles with antitumor activity
ITMI20021040A1 (en) 2002-05-16 2003-11-17 Novuspharma Spa INJECTABLE PHARMACEUTICAL COMPOSITIONS OF AN ANTHROCENEDIONAL DERIVATIVE WITH ANTI-TUMOR ACTIVITY
WO2005097128A1 (en) * 2004-03-30 2005-10-20 Novacea, Inc. 1,4-bis-n-oxide azaanthracenediones and the use thereof
WO2008103320A1 (en) * 2007-02-16 2008-08-28 Novacea, Inc. Methods of treating ophthalmic disorders with anthraquinones
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CL2009002207A1 (en) 2008-12-23 2011-02-18 Gilead Pharmasset Llc Compounds derived from 3-hydroxy-5- (9h-purin-9-yl) tetrahydrofuran-2-yl, an inhibitor of the replication of arn-dependent viral arn; pharmaceutical composition; use for the treatment of hepatitis c.
KR20110104074A (en) 2008-12-23 2011-09-21 파마셋 인코포레이티드 Synthesis of Purine Nucleosides
CL2009002208A1 (en) 2008-12-23 2010-10-29 Gilead Pharmasset Llc A compound (2s) -2 - ((((2r, 3r, 4r, 5r) -5- (2-amino-6-ethoxy-9h-purin-9-yl) -4-fluoro-3-hydroxy-4 -methyltetrahydrofuran-2-yl) methoxy) (hydroxy) phosphorylamino) propanoic acid, viral arn replication inhibitors; pharmaceutical composition; and its use in the treatment of infection with hepatitis c, West Nile virus, among others.
MX2012011171A (en) 2010-03-31 2013-02-01 Gilead Pharmasset Llc Nucleoside phosphoramidates.
CN104513201B (en) * 2013-09-28 2017-12-26 正大天晴药业集团股份有限公司 Crystal of pixantrone maleate
CN104557704B (en) * 2013-10-28 2017-05-10 北京凯莱天成医药科技有限公司 Preparation method of pixantrone maleate
CN103787970A (en) * 2014-01-14 2014-05-14 北京万全德众医药生物技术有限公司 Technology for preparing 6,9-difluoro benzisothiazol-5,10-diketone employing one-pot method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2051005A (en) * 1933-09-19 1936-08-11 Gen Aniline Works Inc Process of producing n-substitution products of 1, 4-diaminoanthraquinones
US2552263A (en) * 1947-09-27 1951-05-08 Eastman Kodak Co alpha-anthrapyridinequinone compounds
ZA774443B (en) * 1977-07-22 1978-06-28 Allied Chem Anthrquinone compounds as anti-cancer agents
US4197249A (en) * 1977-08-15 1980-04-08 American Cyanamid Company 1,4-Bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
EP0270306B1 (en) * 1986-12-01 1991-03-27 Sumitomo Chemical Company, Limited Anthrapyridone compounds, their production process and their use

Similar Documents

Publication Publication Date Title
RU93057572A (en) 6,9-BIS (AMINO-SUBSTITUTED) -BENZO (D) IZOHINOLIN-5,10-DIONA, METHODS OF THEIR RECEIVING, PHARMOCOMPOSITION, METHOD OF TUMOR TREATMENT
RU94027569A (en) ORGANIC SALTS N, N'-DIACETHILTSISTINA, METHOD OF PRODUCTION, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT
RU93004649A (en) TAXAN DERIVATIVES, METHOD OF THEIR PRODUCTION AND USE IN ONCOLOGY, PHARMACOMPOSITION
RU93045710A (en) ANTIVIRAL NUCLEOSIDE COMPOSITION, METHOD OF ITS PRODUCTION AND METHOD OF TREATMENT
CA2029694A1 (en) Heteroatoms-containing tricyclic compounds
DE3875692D1 (en) PATTERN ADMINISTRATION ARRANGEMENT.
RU94002133A (en) 6-CHLOR-5-FTOR-3- (2-TENOIL) -2-OXINDOL-1-CARBOXAMIDE AS AN ANALOGESIC AND ANIMATERATIVE MEDICATION
ITRM930291A0 (en) PROCEDURE FOR THE PREPARATION OF IODINATED BIOPOLYMERS WITH DISINFECTANT AND HEALING ACTIVITY, AND IODINATED BIOPOLYMERS SO OBTAINED.
NO883582D0 (en) CATHODIC ELECTRODEPOSABLE INVESTMENT PREPARATION.
DE69016867D1 (en) Acylated epidermal growth factor.
IT1225474B (en) PROCEDURE FOR THE PREPARATION OF SOLUBLE AND / OR DIVIDABLE TABLETS AND TABS SO OBTAINED.
EP0347749A3 (en) Pyrazoloacridone derivatives with anti-tumoral activity
NO894594L (en) PHARMACEUTICAL COMPOSITIONS INCLUDING LABDAN DITERPENOID DERIVATIVES AND PYRIMIDO (6.1-A) ISOQUINOLIN-4-ONE DERIVATIVES.
DE3880561D1 (en) ACTINONE DERIVATIVES WITH PHYSIOLOGICAL ACTIVITIES.
FI871393A7 (en) Patient bed base.
DE3473826D1 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
RU93052408A (en) ACYLAMINO-ALKYLIDENE-HYDROXY-BIS-PHOSPHONE ACIDS, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION
RU93051079A (en) PHARMACEUTICAL COMPOUNDS, PRODUCTION METHOD, PHARMACEUTICAL COMPOSITION
RU93034452A (en) HINAZOLIN DERIVATIVES FOR ENHANCING ANTI-TUMOR ACTIVITY, METHOD FOR THEIR PRODUCTION, METHOD OF TREATMENT AND PHARMACEUTICAL COMPOSITION
RU93054001A (en) 2,4-DIAMINOCHINAZOLINE DERIVATIVES, METHOD FOR PRODUCING THE PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITING R-GLICOPROTEIN
EP0419354A3 (en) Use of a complex of inosine with a n,n-dialkylamino-alkanol or one of its salts with a pharmacologically acceptable acid for the treatment of certain helmintic infections
IT8722156A0 (en) PYRIDO BENZOIAZINE DERIVATIVES WITH HIGH ANTIBACTERIAL ACTIVITY AND HIGH TISSUE BIOAVAILABILITY.
ITMI911206A1 (en) PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF VASCULAR PERIPHERAL DISEASES BASED ON VINCAMINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT.
RU99121095A (en) METHOD FOR TREATING HEMOPHILIC ARTHROPATHY
AR242498A1 (en) Procedure for the preparation of a pharmaceutical compound, useful for treating vascular infections or illnesses.